XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
 3 Months Ended
Apr. 01, 2017
Mar. 26, 2016
Revenues:    
Net product revenues $ 3,933,142 $ 5,978,134
Research and development revenues 444,985 141,004
Total revenues 4,378,127 6,119,138
Expenses:    
Cost of product revenues 3,117,357 4,636,041
Research and development 4,281,870 4,039,951
Selling, general and administration 5,641,684 3,760,849
Total expenses 13,040,911 12,436,841
Loss from operations (8,662,784) (6,317,703)
Other income and expense:    
Interest income 233,777 164,948
Other income (expense), net 534,411 (39,093)
Foreign currency transaction (losses) (1,191,283) (501,940)
Total other income and expense (423,095) (376,085)
Loss before benefit (provision) for income taxes and net loss (income) attributable to noncontrolling interest (9,085,879) (6,693,788)
Tax benefit (provision) 1,146,000 (141,000)
Net loss (7,939,879) (6,834,788)
Net loss (income) attributable to the noncontrolling interest 81,438 (98,673)
Net loss attributable to the controlling interest $ (7,858,441) $ (6,933,461)
Net (loss) income per share    
Earnings Per Share, Basic $ (0.12) $ (0.11)
Earnings Per Share, Diluted $ (0.12) $ (0.11)
Weighted average number of common shares    
Weighted average common shares outstanding, basic 64,538,686 63,978,048
Weighted average common shares outstanding, diluted 64,538,686 63,978,048